Xcout Intel
Kite
Kite Pharma is a biopharmaceutical company that develops and manufactures custom CAR T-cell therapies to treat certain types of blood cancer. The company utilizes patients' own engineered immune cells to target and attack cancer, serving patients diagnosed with conditions such as lymphomas.
Subscribe to see Kite’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kite at a glance
Kite is a biotech company headquartered in United States. Xcout tracks 1 named person at Kite, including Cindy Perettie (Executive Vice President, Kite). Xcout recorded 3 job postings from Kite in the last 90 days.
Kite leadership
- Cindy PerettieExecutive Vice President, Kite
Hiring at Kite
Xcout recorded 3 job postings from Kite in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Kite's hiring signals →
Tech stack
Kite competitors
A few of Kite's closest competitors — see the full list of competitors and alternatives →
Interius BioTherapeutics is a clinical-stage biotechnology company that engineers targeted, programmable vectors for the precision delivery of genetic medicines. The company develops off-the-shelf CAR T-cell therapies and chimeric antigen receptors intended to treat hematologic malignancies and cancer. Interius BioTherapeutics operates as a subsidiary of Kite, a Gilead company.
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Innovative Cellular Therapeutics is a China-based biotechnology company focused on developing cellular immunotherapies, particularly CAR-T therapies for cancer. It serves patients with hematologic and potentially solid-tumor cancers through clinical development and commercialization of engineered cell therapies.
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Get Kite's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kite? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kite in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access